![](/img/cover-not-exists.png)
964 CLINICAL BENEFIT OF SORAFENIB IN THE ELDERLY WITH ADVANCED RENAL CELL CARCINOMA: SUBGROUP ANALYSIS OF THE APPROACHES IN RENAL CANCER GLOBAL EVALUATION TRIAL (TARGETS)
T. Eisen, S. Oudard, C. Szczylik, G. Gravis, H. Heinzer, R. Middleton, R. Simantov, S. Anderson, R. Bukowski, B. EscudierVolume:
6
Year:
2007
Language:
english
DOI:
10.1016/s1569-9056(07)60959-2
File:
PDF, 318 KB
english, 2007